Effect of Ketalar to Prevent Postoperative Chronic Pain After Mastectomy
Brief Summary
Prevalence of chronic pain after mastectomy is beyond 50% 3 months after surgery. This pain is related to a sensitization of the central nervous system through N-methyl-D-asparate (NMDA) receptors. Ketalar might prevent the occurrence of chronic pain by anti-NMDA properties after mastectomy.
Study Design
| Study type: | Interventional |
|---|---|
| Status: | Unknown status |
| Study results: | No Results Available |
| Age: | 18 Years to 80 Years (Adult, Older Adult) |
| Enrollment: | 40 () |
| Funded by: | Other |
Masking |
|
Clinical Trial Dates
| Start date: | Dec 04, 2020 | |
|---|---|---|
| Primary Completion: | Aug 31, 2020 | |
| Completion Date: | Aug 31, 2020 | |
| Study First Posted: | Aug 12, 2005 | |
| Results First Posted: | Aug 31, 2020 | |
| Last Updated: | Mar 12, 2007 |
Sponsors / Collaborators
Lead Sponsor:
N/A
Responsible Party:
N/A
Eligibility Criteria
| Sex: | Female |
|---|---|
| Minimum Age: | 18 |
| Maximum Age: | 80 |
More Details
| NCT Number: | NCT00129597 |
|---|---|
| Other IDs: | 2004.349 |
| Study URL: | https://ClinicalTrials.gov/show/NCT00129597 |
Last updated: Feb 22, 2021